B+
Bull case
30%
Probability
Target price
$74.00
Analysis reference price unavailable
Analysis 2026-06-29 · RankAlpha Sentiment Codex
FUL
H.B FullerANYSE / Materials
Last Price
Quote time unavailable
Current thesis
The bull case is that Q2 confirmed H.B. Fuller can still grow EBITDA and EPS through pricing, restructuring, and mix even with only modest organic growth, while the AMS transaction could move the company toward a higher-margin medical mix if synergies and deleveraging are delivered.
Posture
Constructive
Lead driver
Sentiment
What changed
Sentiment remains the lead driver in the composite, 7D delta +10.3.
What can break
AMS execution risk is now central: the June 25, 2026 8-K says the deal still requires AMS shareholder approval, UK court sanction, and regulatory approvals, with a long-stop date of June 25, 2027 [#8-K-2026-06-26].
Momentum
19
Value
60
Sentiment
84
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $68.00 · Bull $74.00 · Bear $56.00Analysis 2026-06-29; returns require an exact persisted reference.
Data freshness
Prices
Unavailable: Price unavailable
Fundamentals
As of 2026-08-17 • Vendor: Data Vendor v1
Scores
As of 2026-09-09 • Model: HYBRID_IC_RP
AI Memo
As of 2026-06-29 • Model: RankAlpha Sentiment Codex
Investment thesisAs of 2026-09-09
Investment thesis
As of 2026-09-09
Grade is the composite factor band; factor scores use a 0–100 scale. Confidence describes evidence quality, not a probability of return. Score date: 2026-09-09. Definitions
Supporting evidence
What
Grade A · Constructive
Confidence Medium · Net Neutral
Target $73.29
Why
Momentum19 · Δ7d -1.9
Value60 · Δ7d 0.0
Sentiment84 · Δ7d +10.3
So what
Strength-led posture (Net Neutral). Favor watchlist adds and disciplined entries.
Confirming evidence
- • Sentiment remains the lead driver in the composite, 7D delta +10.3.
Contradictions & invalidation
- • AMS execution risk is now central: the June 25, 2026 8-K says the deal still requires AMS shareholder approval, UK court sanction, and regulatory approvals, with a long-stop date of June 25, 2027 [#8-K-2026-06-26].
- • Leverage risk rises if AMS closes before synergies are realized; secondary earnings-follow-up coverage indicated net debt to adjusted EBITDA could move to roughly 4x post-close, which narrows room for error.
- • The bear case is that investors may treat the earnings beat as lower quality if volume stays soft, raw-material inflation remains sticky, and the AMS deal pushes leverage higher before benefits are realized.
Catalyst clock
2026-09-23
Q2 beat plus higher FY2026 EBITDA/EPS outlook resets the near-term baseline
Lead driver: Sentiment · See AI snapshot
Momentum
19
9% active weight
Current posture
7d trendFlat
Δ7d
-1.9
Δ21d
-31.9
Value
60
28% active weight
Current posture
7d trendFlat
Δ7d
0.0
Δ21d
-0.3
Sentiment
84
62% active weight
Current posture
7d trendImproving
Δ7d
+10.3
Δ21d
+20.3
Why this grade
Composite grade A. Momentum 18.5 / Value 59.6 / Sentiment 84.4
Scenario snapshot
Scenario probability is memo-authored likelihood, not forecast certainty. Targets belong to the analysis dated 2026-06-29. Scenario method
Most likely
B
Base case
45%
Probability
Target price
$68.00
Analysis reference price unavailable
Analysis 2026-06-29 · RankAlpha Sentiment Codex
B-
Bear case
25%
Probability
Target price
$56.00
Analysis reference price unavailable
Analysis 2026-06-29 · RankAlpha Sentiment Codex
Fundamentals (TTM)As of 2026-08-17
Fundamentals (TTM)
As of 2026-08-17
Market Cap
$3.42B
Beta
1.10
Shares Out
53.79M
P/E (TTM)
28.7
P/S (TTM)
0.92
P/FCF (TTM)
45.07
Rev YoY
+5.8%
EPS YoY
+61.8%
Gross Margin
+32.4%
Op Margin
+11.3%
Net Debt
$1.98B
Current Ratio
1.80
As of 2026-09-09 • Updated nightlySource: Internal modelMethods & Data